Cutler Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-49,400
| Closed | -$1.44M | – | 6435 |
|
|
2021
Q4 | $1.44M | Sell |
49,400
-11,600
| -19% | -$764K | 0.06% | 343 |
|
|
2021
Q3 | $803K | Buy |
+61,000
| New | +$3.6M | 0.04% | 558 |
|
|
2020
Q4 | – | Sell |
-4,900
| Closed | -$56K | – | 5755 |
|
|
2020
Q3 | $56K | Buy |
4,900
+1,900
| +63% | +$127K | ﹤0.01% | 1735 |
|
|
2020
Q2 | $51K | Buy |
+3,000
| New | +$165K | ﹤0.01% | 1741 |
|
|
2019
Q4 | – | Sell |
-1,900
| Closed | -$1K | – | 4859 |
|
|
2019
Q3 | $1K | Buy |
1,900
+1,700
| +850% | +$95.6K | ﹤0.01% | 3915 |
|
|
2019
Q2 | $1K | Sell |
200
-1,700
| -89% | -$87.9K | ﹤0.01% | 4086 |
|
|
2019
Q1 | $1K | Sell |
1,900
-2,400
| -56% | -$110K | ﹤0.01% | 3876 |
|
|
2018
Q4 | $2K | Sell |
4,300
-3,200
| -43% | -$126K | ﹤0.01% | 3489 |
|
|
2018
Q3 | $39K | Sell |
7,500
-2,200
| -23% | -$89.2K | ﹤0.01% | 1778 |
|
|
2018
Q2 | $43K | Sell |
9,700
-5,900
| -38% | -$254K | ﹤0.01% | 1708 |
|
|
2018
Q1 | $68K | Sell |
15,600
-20,400
| -57% | -$794K | 0.01% | 1454 |
|
|
2017
Q4 | $89K | Buy |
36,000
+3,200
| +10% | +$91.2K | ﹤0.01% | 1452 |
|
|
2017
Q3 | $16K | Buy |
32,800
+2,200
| +7% | +$50.5K | ﹤0.01% | 3371 |
|
|
2017
Q2 | $15K | Buy |
30,600
+27,310
| +830% | +$374K | ﹤0.01% | 3758 |
|
|
2017
Q1 | $9K | Buy |
+3,290
| New | +$48.7K | ﹤0.01% | 4200 |
|
Cutler Group's ARNA Position: Q1 2022 in Review
Cutler Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 40,913 shares — an estimated $3.8M sold.
Cutler Group first reported a position in ARNA in Q2 2017 and held it in 15 quarters. The position peaked at $3.8M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Cutler Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Cutler Group sold 40,913 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.8M.
- Cutler Group first reported a position in Arena Pharmaceuticals Inc in Q2 2017 and held it in 15 quarters.
- Cutler Group's Arena Pharmaceuticals Inc position peaked at $3.8M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Cutler Group's 13F filing for Q1 2022, filed 14 Apr 2022.